Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 April 2019 | Story Ruan Bruwer | Photo Varsity Cup
Lubabalo Dobela
Flyhalf Lubabalo Dobela will be an important cog in the wheel for the Shimlas against the Maties in the semi-final stage of the Varsity Cup. He has been named Player that Rocks twice this year.

The Shimlas (University of the Free State) will go into the semi-final against the unbeaten Maties with confidence, knowing that they can compete against them, said coach Hendro Scholtz.

The Shimlas will travel to Stellenbosch for the Varsity Cup clash on Monday (8 April). They qualified for the play-offs thanks to a 38-14 victory over the University of Johannesburg (UJ) in the final round of the competition on Monday 1 April 2019.

The Free State students lost to the Maties by 59-14 two weeks ago, and although the score reflects a big hiding, the Shimlas stood tall for most of the encounter.

“With 18 minutes remaining, we trailed by only ten points (14-24). We can gain confidence from that. We learned a couple of things about them. We will have to stop their driving mall and be sharp when it comes to our discipline. They will hurt us if we concede penalties,” said Scholtz.

According to him, it is important to get off to a good start. “You often sit with students who have other things to think about apart from rugby, such as upcoming tests, which can hamper their concentration. Against UJ in the wet, it was important to play the conditions right, and I think it made the players concentrate that little bit more.”

The Shimlas won four of their eight group matches and will look back on their defeats against the Pukke and Ixias as matches that they could easily have won on another day.

It is the fifth time in the 12 years of the Varsity Cup that the Shimlas have reached the final-four stage, with one win in 2015 over the Ikeys.

The Shimlas will be without two of their key men among the forwards – the injured flank Janco Cloete and hooker Hanno Snyman.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept